ViroPharma to Present at the UBS Global Life Sciences Conference

Wednesday, September 19, 2007 General News J E 4
EXTON, Pa., Sept. 18 ViroPharma Incorporated(Nasdaq: VPHM) today announced that Michel de Rosen, president and chiefexecutive officer of ViroPharma, will present at the UBS Global Life SciencesConference at 4:00 P.M. ET on Tuesday, September 25, 2007. The conference isbeing held at the Grand Hyatt in New York.

ViroPharma's presentation will be webcast live for investors and available through October 4, 2007.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to thedevelopment and commercialization of products that address serious diseasestreated by physician specialists and in hospital settings. ViroPharmacommercializes Vancocin(R), approved for oral administration for treatment ofantibiotic-associated pseudomembranous colitis caused by Clostridium difficileand enterocolitis caused by Staphylococcus aureus, includingmethicillin-resistant strains (for prescribing information, please downloadthe package insert at currently focuses its drug development activities in viral diseasesincluding cytomegalovirus (CMV) and hepatitis C (HCV). For more information onViroPharma, visit the company's website at

SOURCE ViroPharma Incorporated


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
The American Pain Foundation (APF) and The HealthC...
Triveris Introduces Personal Health Record with Bu...